PDI AND GLUTATHIONE-MEDIATED REDUCTION OF THE GLUTATHIONYLATED VARIANT OF HUMAN LYSOZYME

被引:26
|
作者
HAYANO, T
INAKA, K
OTSU, M
TANIYAMA, Y
MIKI, K
MATSUSHIMA, M
KIKUCHI, M
机构
[1] PROTEIN ENGN RES INST,6-2-3 FURUEDAI,SUITA,OSAKA 565,JAPAN
[2] TOKYO INST TECHNOL,RESOURCES UTILIZAT RES LAB,MIDORI KU,YOKOHAMA 227,JAPAN
关键词
PROTEIN DISULFIDE ISOMERASE; PROTEIN FOLDING; GLUTATHIONE; LYSOZYME;
D O I
10.1016/0014-5793(93)80993-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A mutant human lysozyme, designated as C77A-a, in which glutathione is bound to Cys95, has been shown to mimic an intermediate in the formation of a disulfide bond during folding of human (h)-lysozyme. Protein disulfide isomerase (PDI), which is believed to catalyze disulfide bond formation and associated protein folding in the endoplasmic reticulum, attacked the glutathionylated h-lysozyme C77A-a to dissociate the glutathione molecule. Structural analyses showed that the protein is folded and that the structure around the disulfide bond, buried in a hydrophobic core, between the protein and the bound glutathione is fairly rigid. Thioredoxin, which has higher reducing activity of protein disulfides than PDI, catalyzed the reduction with lower efficiency. These results strongly suggest that PDI can catalyze the disulfide formation in intermediates with compact structure like the native states in the later step of in vivo protein folding.
引用
收藏
页码:203 / 208
页数:6
相关论文
共 50 条
  • [31] STRUCTURE OF A GLUTATHIONYLATED HUMAN LYSOZYME - A FOLDING INTERMEDIATE MIMIC IN THE FORMATION OF A DISULFIDE BOND
    INAKA, K
    MIKI, K
    ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1995, 51 : 619 - 625
  • [32] Physiological melatonin inhibition of human breast cancer cell growth in vitro: Evidence for a glutathione-mediated pathway
    Blask, DE
    Wilson, ST
    Zalatan, F
    CANCER RESEARCH, 1997, 57 (10) : 1909 - 1914
  • [33] Glutathione-mediated formation of oxygen free radicals by the major metabolite of oltipraz
    Velayutham, M
    Villamena, FA
    Navamal, M
    Fishbein, JC
    Zweier, JL
    CHEMICAL RESEARCH IN TOXICOLOGY, 2005, 18 (06) : 970 - 975
  • [34] Kinetics of inhibition of glutathione-mediated degradation of ferriprotoporphyrin IX by antimalarial drugs
    Famin, O
    Krugliak, M
    Ginsburg, H
    BIOCHEMICAL PHARMACOLOGY, 1999, 58 (01) : 59 - 68
  • [35] DEFICIENT GLUTATHIONE-MEDIATED PROTECTION AGAINST XENOBIOTIC ATTACK IN PERIVENOUS HEPATOCYTES
    LINDROS, KO
    KERA, Y
    PENTTILA, K
    ALCOHOL AND ALCOHOLISM, 1987, 22 (03): : A5 - A5
  • [36] Glutathione-Mediated Metal Tolerance in an Amphibian Chytrid Fungus (Batrachochytrium dendrobatidis)
    Webb, Rebecca J.
    Cuff, Christopher
    Berger, Lee
    ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY, 2024, 43 (07) : 1583 - 1591
  • [37] GLUTATHIONE-MEDIATED TRANSPORT ACROSS INTESTINAL BRUSH-BORDER MEMBRANES
    VINCENZINI, MT
    FAVILLI, F
    IANTOMASI, T
    BIOCHIMICA ET BIOPHYSICA ACTA, 1988, 942 (01) : 107 - 114
  • [38] Glutathione-Mediated Biodegradable Polyurethanes Derived from L-Arabinitol
    Violante de Paz, M.
    Zamora, Francisca
    Begines, Belen
    Ferris, Cristina
    Galbis, Juan A.
    BIOMACROMOLECULES, 2010, 11 (01) : 269 - 276
  • [39] Glutathione-mediated augmentation of β-lactam antibacterial activity against Escherichia coli
    Goswami, Manish
    Jawali, Narendra
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 60 (01) : 184 - 185
  • [40] Glutathione-mediated delivery and release using monolayer protected nanoparticle carriers
    Hong, R
    Han, G
    Fernández, JM
    Kim, BJ
    Forbes, NS
    Rotello, VM
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2006, 128 (04) : 1078 - 1079